ProCE Banner Activity

Myelodysplastic Syndromes: Questions for Your Care Team

PDF
Download this patient-focused resource detailing key questions patients can ask their healthcare team after a diagnosis of myelodysplastic syndrome.

Released: October 15, 2021

Expiration: October 14, 2022

No longer available for credit.

Share

Faculty

Sara Tinsley-Vance

Sara Tinsley-Vance, PhD, MSN, APRN-BC, AOCN

Nurse Practitioner and Researcher
Malignant Hematology
Moffitt Cancer Center
Tampa, Florida

Provided by

Provided by Rush University Medical Center in partnership with Clinical Care Options, LLC, and the MDS Foundation.
ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb

Partners

MDS Foundation

ProCE Banner

Faculty Disclosure

Primary Author

Sara Tinsley-Vance, PhD, MSN, APRN-BC, AOCN

Nurse Practitioner and Researcher
Malignant Hematology
Moffitt Cancer Center
Tampa, Florida

Sara Tinsley, PhD, ARNP, AOCN has disclosed that she has received consulting fees from AbbVie, Bristol-Myers Squibb, Incyte, Jazz, Novartis, and Taiho and non-CME fees from Bristol-Myers Squibb, Incyte, and Jazz.